Ausdal Financial Partners, Inc. Teva Pharmaceutical Industries LTD Transaction History

Ausdal Financial Partners, Inc.

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$7.33 - $9.39 $76,891 - $98,501	-10,490 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$7.9 - $10.19 $17,538 - $22,621	-2,220 Reduced 17.47%	10,490 $84,000
Q3 2021 Nov 01, 2021	SELL	$8.38 - $10.18 $41,129 - $49,963	-4,908 Reduced 27.86%	12,710 $124,000
Q1 2021 May 05, 2021	SELL	$10.34 - $12.81 $79,928 - $99,021	-7,730 Reduced 30.5%	17,618 $203,000
Q4 2020 Feb 01, 2021	BUY	$8.61 - $11.04 $16,789 - $21,528	1,950 Added 8.33%	25,348 $130,000
Q3 2020 Nov 04, 2020	BUY	$8.57 - $12.69 $102,154 - $151,264	11,920 Added 103.85%	23,398 $107,000
Q2 2020 Aug 06, 2020	BUY	$8.12 - $13.12 $93,201 - $150,591	11,478 New	11,478 $142,000
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $102,214 - $167,800	-15,653 Closed	0 $0
Q3 2019 Nov 19, 2019	BUY	$6.16 - $9.6 $28,952 - $45,120	4,700 Added 42.91%	15,653 $108,000
Q2 2019 Aug 05, 2019	SELL	$8.12 - $15.72 $1,217 - $2,358	-150 Reduced 1.35%	10,953 $87,000
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $1,230 - $1,580	-79 Reduced 0.71%	11,103 $174,000
Q4 2018 Feb 11, 2019	SELL	$14.59 - $23.84 $80,974 - $132,312	-5,550 Reduced 33.17%	11,182 $172,000
Q3 2018 Nov 09, 2018	BUY	$21.06 - $25.65 $22,955 - $27,958	1,090 Added 6.97%	16,732 $360,000
Q1 2018 Apr 20, 2018	BUY	$16.68 - $22.07 $260,908 - $345,218	15,642 New	15,642 $267,000
Q4 2017 Feb 08, 2018	SELL	$11.23 - $19.1 $139,993 - $238,100	-12,466 Closed	0 $0
Q3 2017 Oct 31, 2017	BUY	$15.41 - $32.17 $192,101 - $401,031	12,466	12,466 $219,000

626

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $18.3B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Ausdal Financial Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ausdal Financial Partners, Inc. with notifications on news.